Browse Entries
1095 results — Clear filters
Filters
| PDB ID | Title | Organism | UniProt | Res. (Å) | Oligo | QSbio Err |
|---|---|---|---|---|---|---|
| 5PZY | Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) complexed with the allosteric inhibitor 1-(5-bromo-1,3-thiazol-2-yl)-3-(2-chlorophenyl)sulfonylurea | Homo sapiens | Q2Tu34 | 2.21 | 4mer | 2.700 |
| 5PZZ | Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) complexed with the allosteric inhibitor 1-(5-bromo-1,3-thiazol-2-yl)-3-(3,4-dichlorophenyl)sulfonylurea | Homo sapiens | Q2Tu34 | 2.50 | 4mer | 2.700 |
| 5Q00 | Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) complexed with the allosteric inhibitor 2-[3-[(5-bromo-1,3-thiazol-2-yl)carbamoylsulfamoyl]-1-methylindol-7-yl]oxyacetamide | Homo sapiens | Q2Tu34 | 2.60 | 4mer | 2.700 |
| 5Q01 | Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) complexed with the allosteric inhibitor 1-(5-bromo-1,3-thiazol-2-yl)-3-[4-(4,5-dichloro-2-methylpyrazol-3-yl)oxyphenyl]sulfonylurea | Homo sapiens | Q2Tu34 | 2.60 | 4mer | 3.600 |
| 5Q02 | Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) complexed with the allosteric inhibitor 1-(5-bromo-1,3-thiazol-2-yl)-3-[5-(1,2-oxazol-3-yl)thiophen-2-yl]sulfonylurea | Homo sapiens | Q2Tu34 | 2.10 | 4mer | 2.700 |
| 5Q03 | Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) complexed with the allosteric inhibitor 1-(5-bromo-1,3-thiazol-2-yl)-3-[5-(2-methylpropyl)thiophen-2-yl]sulfonylurea | Homo sapiens | Q2Tu34 | 2.31 | 4mer | 2.700 |
| 5Q04 | Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) complexed with the allosteric inhibitor 1-(4-bromo-5-chlorothiophen-2-yl)sulfonyl-3-(5-bromo-1,3-thiazol-2-yl)urea | Homo sapiens | Q2Tu34 | 2.50 | 4mer | 2.700 |
| 5Q05 | Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) complexed with the allosteric inhibitor 1-(5-bromo-1,3-thiazol-2-yl)-3-[5-(2-methoxyethyl)-4-methylthiophen-2-yl]sulfonylurea | Homo sapiens | Q2Tu34 | 2.20 | 4mer | 2.700 |
| 5Q06 | Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) complexed with the allosteric inhibitor 1-(5-bromo-1,3-thiazol-2-yl)-3-[4-(2-methyl-1,3-thiazol-4-yl)phenyl]sulfonylurea | Homo sapiens | Q2Tu34 | 2.40 | 4mer | 2.700 |
| 5Q07 | Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) complexed with the allosteric inhibitor 1-(4-bromo-6-morpholin-4-ylpyridin-2-yl)-3-[5-(2-methoxyethyl)-4-methylthiophen-2-yl]sulfonylurea | Homo sapiens | Q2Tu34 | 2.42 | 4mer | 2.700 |
| 5Q08 | Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) complexed with the allosteric inhibitor 1-(1-benzothiophen-3-ylsulfonyl)-3-(5-bromo-1,3-thiazol-2-yl)urea | Homo sapiens | Q2Tu34 | 2.20 | 4mer | 2.700 |
| 5Q09 | Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) complexed with the allosteric inhibitor 1-[4-bromo-6-(carbamoylamino)pyridin-2-yl]-3-[5-(2-methoxyethyl)-4-methylthiophen-2-yl]sulfonylurea | Homo sapiens | Q2Tu34 | 1.90 | 4mer | 2.700 |
| 5Q0A | Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) complexed with the allosteric inhibitor 1-(5-cyanopyrazin-2-yl)-3-[3-(difluoromethoxy)phenyl]sulfonylurea | Homo sapiens | Q2Tu34 | 2.30 | 4mer | 2.700 |
| 5Q0B | Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) complexed with the allosteric inhibitor 1-(4-bromo-3-methyl-1,2-thiazol-5-yl)-3-(3-methylphenyl)sulfonylurea | Homo sapiens | Q2Tu34 | 2.30 | 4mer | 2.700 |
| 5QDF | PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000295a | Homo sapiens | P18031 | 1.71 | 1mer | 1.800 |
| 5QGF | PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOOA000539a | Homo sapiens | P18031 | 1.51 | 1mer | 1.800 |
| 5SUN | IDH1 R132H in complex with IDH146 | Homo sapiens | O75874 | 2.48 | 2mer | 7.300 |
| 5SVF | IDH1 R132H in complex with IDH125 | Homo sapiens | O75874 | 2.34 | 2mer | 2.100 |
| 5T19 | Structure of PTP1B complexed with N-(3'-(1,1-dioxido-4-oxo-1,2,5-thiadiazolidin-2-yl)-4'-methyl-[1,1'-biphenyl]-4-yl)acetamide | Homo sapiens | P18031 | 2.10 | 1mer | 1.800 |
| 5T1A | Structure of CC Chemokine Receptor 2 with Orthosteric and Allosteric Antagonists | Homo sapiens | P41597 | 2.80 | 1mer | 1.800 |
| 5TF9 | Crystal structure of WNK1 in complex with Mn2+AMPPNP and WNK476 | Homo sapiens | Q9H4A3 | 2.50 | 1mer | 46.300 |
| 5TKB | Crystal Structure Of Human Phosphodiesterase 4D In Complex With A Tetrafluoranline Compound | Homo sapiens | Q08499 | 2.16 | 1mer | 13.900 |
| 5TKD | Crystal Structure Of Tyrosine Kinase 2 Jh2 (Pseudo Kinase Domain) Complexed With 6-[(3,5-Dimethylphe Nyl)Amino]-8- (Methylamino)Imidazo[1,2-B]Pyridazine-3-Carbo Xamide | Homo sapiens | P29597 | 1.92 | 1mer | 5.800 |
| 5TQH | IDH1 R132H mutant in complex with IDH889 | Homo sapiens | O75874 | 2.20 | 2mer | 2.100 |
| 5TTW | Crystal Structure of EED in Complex with UNC4859 | Homo sapiens | O75530 | 1.74 | 1mer | 12.900 |